OCH is a glycolipid antigen and a ligand of iNKT cells that promotes IL‐4 secretion, and it has been tested in clinical trials for the treatment of Crohn's disease and multiple sclerosis.38 The gene discussed is IL4; the disease is multiple sclerosis.